Mona L Gauthier, Hal K Berman, Caroline Miller, Krystyna Kozakeiwicz, Karen Chew, Dan Moore, Joseph Rabban, Yunn Yi Chen, Karla Kerlikowske, Thea D Tlsty. Cancer Cell 2007
Times Cited: 170
Times Cited: 170
Times Cited
Times Co-cited
Similarity
Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
25
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
21
Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
21
The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas.
Jason I Herschkowitz, Xiaping He, Cheng Fan, Charles M Perou. Breast Cancer Res 2008
Jason I Herschkowitz, Xiaping He, Cheng Fan, Charles M Perou. Breast Cancer Res 2008
19
Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically.
Andrea Proctor Subhawong, Ty Subhawong, Hind Nassar, Nina Kouprina, Shahnaz Begum, Russell Vang, William H Westra, Pedram Argani. Am J Surg Pathol 2009
Andrea Proctor Subhawong, Ty Subhawong, Hind Nassar, Nina Kouprina, Shahnaz Begum, Russell Vang, William H Westra, Pedram Argani. Am J Surg Pathol 2009
16
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
14
Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.
Zhe Jiang, Tao Deng, Robert Jones, Huiqin Li, Jason I Herschkowitz, Jeff C Liu, Victor J Weigman, Ming-Sound Tsao, Timothy F Lane, Charles M Perou,[...]. J Clin Invest 2010
Zhe Jiang, Tao Deng, Robert Jones, Huiqin Li, Jason I Herschkowitz, Jeff C Liu, Victor J Weigman, Ming-Sound Tsao, Timothy F Lane, Charles M Perou,[...]. J Clin Invest 2010
14
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
Torsten O Nielsen, Forrest D Hsu, Kristin Jensen, Maggie Cheang, Gamze Karaca, Zhiyuan Hu, Tina Hernandez-Boussard, Chad Livasy, Dave Cowan, Lynn Dressler,[...]. Clin Cancer Res 2004
Torsten O Nielsen, Forrest D Hsu, Kristin Jensen, Maggie Cheang, Gamze Karaca, Zhiyuan Hu, Tina Hernandez-Boussard, Chad Livasy, Dave Cowan, Lynn Dressler,[...]. Clin Cancer Res 2004
12
Repeated observation of breast tumor subtypes in independent gene expression data sets.
Therese Sorlie, Robert Tibshirani, Joel Parker, Trevor Hastie, J S Marron, Andrew Nobel, Shibing Deng, Hilde Johnsen, Robert Pesich, Stephanie Geisler,[...]. Proc Natl Acad Sci U S A 2003
Therese Sorlie, Robert Tibshirani, Joel Parker, Trevor Hastie, J S Marron, Andrew Nobel, Shibing Deng, Hilde Johnsen, Robert Pesich, Stephanie Geisler,[...]. Proc Natl Acad Sci U S A 2003
12
Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.
Yoshimi Arima, Yasumichi Inoue, Tatsuhiro Shibata, Hidemi Hayashi, Osamu Nagano, Hideyuki Saya, Yoichi Taya. Cancer Res 2008
Yoshimi Arima, Yasumichi Inoue, Tatsuhiro Shibata, Hidemi Hayashi, Osamu Nagano, Hideyuki Saya, Yoichi Taya. Cancer Res 2008
12
Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment.
Agnieszka K Witkiewicz, Dayana B Rivadeneira, Adam Ertel, Jessica Kline, Terry Hyslop, Gordon F Schwartz, Paolo Fortina, Erik S Knudsen. Am J Pathol 2011
Agnieszka K Witkiewicz, Dayana B Rivadeneira, Adam Ertel, Jessica Kline, Terry Hyslop, Gordon F Schwartz, Paolo Fortina, Erik S Knudsen. Am J Pathol 2011
33
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
Chad A Livasy, Gamze Karaca, Rita Nanda, Maria S Tretiakova, Olufunmilayo I Olopade, Dominic T Moore, Charles M Perou. Mod Pathol 2006
Chad A Livasy, Gamze Karaca, Rita Nanda, Maria S Tretiakova, Olufunmilayo I Olopade, Dominic T Moore, Charles M Perou. Mod Pathol 2006
10
The molecular portraits of breast tumors are conserved across microarray platforms.
Zhiyuan Hu, Cheng Fan, Daniel S Oh, J S Marron, Xiaping He, Bahjat F Qaqish, Chad Livasy, Lisa A Carey, Evangeline Reynolds, Lynn Dressler,[...]. BMC Genomics 2006
Zhiyuan Hu, Cheng Fan, Daniel S Oh, J S Marron, Xiaping He, Bahjat F Qaqish, Chad Livasy, Lisa A Carey, Evangeline Reynolds, Lynn Dressler,[...]. BMC Genomics 2006
10
Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.
D Craig Allred, Yun Wu, Sufeng Mao, Iris D Nagtegaal, Sangjun Lee, Charles M Perou, Syed K Mohsin, Peter O'Connell, Anna Tsimelzon, Dan Medina. Clin Cancer Res 2008
D Craig Allred, Yun Wu, Sufeng Mao, Iris D Nagtegaal, Sangjun Lee, Charles M Perou, Syed K Mohsin, Peter O'Connell, Anna Tsimelzon, Dan Medina. Clin Cancer Res 2008
10
Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.
Anne Vincent-Salomon, Carlo Lucchesi, Nadège Gruel, Virginie Raynal, Gaëlle Pierron, Rémi Goudefroye, Fabien Reyal, François Radvanyi, Rémy Salmon, Jean-Paul Thiery,[...]. Clin Cancer Res 2008
Anne Vincent-Salomon, Carlo Lucchesi, Nadège Gruel, Virginie Raynal, Gaëlle Pierron, Rémi Goudefroye, Fabien Reyal, François Radvanyi, Rémy Salmon, Jean-Paul Thiery,[...]. Clin Cancer Res 2008
10
Cellular mechanisms of tumour suppression by the retinoblastoma gene.
Deborah L Burkhart, Julien Sage. Nat Rev Cancer 2008
Deborah L Burkhart, Julien Sage. Nat Rev Cancer 2008
10
Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, Maggie C U Cheang, Samuel Leung, David Voduc, Tammi Vickery, Sherri Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu,[...]. J Clin Oncol 2009
Joel S Parker, Michael Mullins, Maggie C U Cheang, Samuel Leung, David Voduc, Tammi Vickery, Sherri Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu,[...]. J Clin Oncol 2009
9
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.
Koei Chin, Sandy DeVries, Jane Fridlyand, Paul T Spellman, Ritu Roydasgupta, Wen-Lin Kuo, Anna Lapuk, Richard M Neve, Zuwei Qian, Tom Ryder,[...]. Cancer Cell 2006
Koei Chin, Sandy DeVries, Jane Fridlyand, Paul T Spellman, Ritu Roydasgupta, Wen-Lin Kuo, Anna Lapuk, Richard M Neve, Zuwei Qian, Tom Ryder,[...]. Cancer Cell 2006
9
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
Lisa A Carey, E Claire Dees, Lynda Sawyer, Lisa Gatti, Dominic T Moore, Frances Collichio, David W Ollila, Carolyn I Sartor, Mark L Graham, Charles M Perou. Clin Cancer Res 2007
Lisa A Carey, E Claire Dees, Lynda Sawyer, Lisa Gatti, Dominic T Moore, Frances Collichio, David W Ollila, Carolyn I Sartor, Mark L Graham, Charles M Perou. Clin Cancer Res 2007
9
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.
Elgene Lim, François Vaillant, Di Wu, Natasha C Forrest, Bhupinder Pal, Adam H Hart, Marie-Liesse Asselin-Labat, David E Gyorki, Teresa Ward, Audrey Partanen,[...]. Nat Med 2009
Elgene Lim, François Vaillant, Di Wu, Natasha C Forrest, Bhupinder Pal, Adam H Hart, Marie-Liesse Asselin-Labat, David E Gyorki, Teresa Ward, Audrey Partanen,[...]. Nat Med 2009
9
HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.
E Rakovitch, S Nofech-Mozes, W Hanna, S Narod, D Thiruchelvam, R Saskin, J Spayne, C Taylor, L Paszat. Br J Cancer 2012
E Rakovitch, S Nofech-Mozes, W Hanna, S Narod, D Thiruchelvam, R Saskin, J Spayne, C Taylor, L Paszat. Br J Cancer 2012
10
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
9
Tailoring to RB: tumour suppressor status and therapeutic response.
Erik S Knudsen, Karen E Knudsen. Nat Rev Cancer 2008
Erik S Knudsen, Karen E Knudsen. Nat Rev Cancer 2008
9
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
Jason I Herschkowitz, Karl Simin, Victor J Weigman, Igor Mikaelian, Jerry Usary, Zhiyuan Hu, Karen E Rasmussen, Laundette P Jones, Shahin Assefnia, Subhashini Chandrasekharan,[...]. Genome Biol 2007
Jason I Herschkowitz, Karl Simin, Victor J Weigman, Igor Mikaelian, Jerry Usary, Zhiyuan Hu, Karen E Rasmussen, Laundette P Jones, Shahin Assefnia, Subhashini Chandrasekharan,[...]. Genome Biol 2007
8
Breast cancer molecular subtypes respond differently to preoperative chemotherapy.
Roman Rouzier, Charles M Perou, W Fraser Symmans, Nuhad Ibrahim, Massimo Cristofanilli, Keith Anderson, Kenneth R Hess, James Stec, Mark Ayers, Peter Wagner,[...]. Clin Cancer Res 2005
Roman Rouzier, Charles M Perou, W Fraser Symmans, Nuhad Ibrahim, Massimo Cristofanilli, Keith Anderson, Kenneth R Hess, James Stec, Mark Ayers, Peter Wagner,[...]. Clin Cancer Res 2005
8
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
Cornelia Liedtke, Chafika Mazouni, Kenneth R Hess, Fabrice André, Attila Tordai, Jaime A Mejia, W Fraser Symmans, Ana M Gonzalez-Angulo, Bryan Hennessy, Marjorie Green,[...]. J Clin Oncol 2008
Cornelia Liedtke, Chafika Mazouni, Kenneth R Hess, Fabrice André, Attila Tordai, Jaime A Mejia, W Fraser Symmans, Ana M Gonzalez-Angulo, Bryan Hennessy, Marjorie Green,[...]. J Clin Oncol 2008
8
The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer.
William D Foulkes, Jean-Sébastien Brunet, Ingunn M Stefansson, Oddbjørn Straume, Pierre O Chappuis, Louis R Bégin, Nancy Hamel, John R Goffin, Nora Wong, Michel Trudel,[...]. Cancer Res 2004
William D Foulkes, Jean-Sébastien Brunet, Ingunn M Stefansson, Oddbjørn Straume, Pierre O Chappuis, Louis R Bégin, Nancy Hamel, John R Goffin, Nora Wong, Michel Trudel,[...]. Cancer Res 2004
8
Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
Karla Kerlikowske, Annette Molinaro, Imok Cha, Britt-Marie Ljung, Virginia L Ernster, Kim Stewart, Karen Chew, Dan H Moore, Fred Waldman. J Natl Cancer Inst 2003
Karla Kerlikowske, Annette Molinaro, Imok Cha, Britt-Marie Ljung, Virginia L Ernster, Kim Stewart, Karen Chew, Dan H Moore, Fred Waldman. J Natl Cancer Inst 2003
8
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
Brian D Lehmann, Joshua A Bauer, Xi Chen, Melinda E Sanders, A Bapsi Chakravarthy, Yu Shyr, Jennifer A Pietenpol. J Clin Invest 2011
Brian D Lehmann, Joshua A Bauer, Xi Chen, Melinda E Sanders, A Bapsi Chakravarthy, Yu Shyr, Jennifer A Pietenpol. J Clin Invest 2011
8
Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
8
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
8
Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review.
Sara A Lari, Henry M Kuerer. J Cancer 2011
Sara A Lari, Henry M Kuerer. J Cancer 2011
8
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer.
Emily E Bosco, Ying Wang, Huan Xu, Jack T Zilfou, Karen E Knudsen, Bruce J Aronow, Scott W Lowe, Erik S Knudsen. J Clin Invest 2007
Emily E Bosco, Ying Wang, Huan Xu, Jack T Zilfou, Karen E Knudsen, Bruce J Aronow, Scott W Lowe, Erik S Knudsen. J Clin Invest 2007
8
Triple-negative breast cancer: clinical features and patterns of recurrence.
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
7
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
Maggie C U Cheang, David Voduc, Chris Bajdik, Samuel Leung, Steven McKinney, Stephen K Chia, Charles M Perou, Torsten O Nielsen. Clin Cancer Res 2008
Maggie C U Cheang, David Voduc, Chris Bajdik, Samuel Leung, Steven McKinney, Stephen K Chia, Charles M Perou, Torsten O Nielsen. Clin Cancer Res 2008
7
Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.
Katrina R Bauer, Monica Brown, Rosemary D Cress, Carol A Parise, Vincent Caggiano. Cancer 2007
Katrina R Bauer, Monica Brown, Rosemary D Cress, Carol A Parise, Vincent Caggiano. Cancer 2007
7
Basal-like breast cancer: a critical review.
Emad A Rakha, Jorge S Reis-Filho, Ian O Ellis. J Clin Oncol 2008
Emad A Rakha, Jorge S Reis-Filho, Ian O Ellis. J Clin Oncol 2008
7
Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.
Laura G Fulford, Jorge S Reis-Filho, Ken Ryder, Chris Jones, Cheryl E Gillett, Andrew Hanby, Douglas Easton, Sunil R Lakhani. Breast Cancer Res 2007
Laura G Fulford, Jorge S Reis-Filho, Ken Ryder, Chris Jones, Cheryl E Gillett, Andrew Hanby, Douglas Easton, Sunil R Lakhani. Breast Cancer Res 2007
7
Gene expression profiles of human breast cancer progression.
Xiao-Jun Ma, Ranelle Salunga, J Todd Tuggle, Justin Gaudet, Edward Enright, Philip McQuary, Terry Payette, Maria Pistone, Kimberly Stecker, Brian M Zhang,[...]. Proc Natl Acad Sci U S A 2003
Xiao-Jun Ma, Ranelle Salunga, J Todd Tuggle, Justin Gaudet, Edward Enright, Philip McQuary, Terry Payette, Maria Pistone, Kimberly Stecker, Brian M Zhang,[...]. Proc Natl Acad Sci U S A 2003
7
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro.
Richard S Finn, Judy Dering, Dylan Conklin, Ondrej Kalous, David J Cohen, Amrita J Desai, Charles Ginther, Mohammad Atefi, Isan Chen, Camilla Fowst,[...]. Breast Cancer Res 2009
Richard S Finn, Judy Dering, Dylan Conklin, Ondrej Kalous, David J Cohen, Amrita J Desai, Charles Ginther, Mohammad Atefi, Isan Chen, Camilla Fowst,[...]. Breast Cancer Res 2009
7
Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype.
K Milde-Langosch, A M Bamberger, G Rieck, B Kelp, T Löning. Breast Cancer Res Treat 2001
K Milde-Langosch, A M Bamberger, G Rieck, B Kelp, T Löning. Breast Cancer Res Treat 2001
7
Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
7
National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.
Carmen J Allegra, Denise R Aberle, Pamela Ganschow, Stephen M Hahn, Clara N Lee, Sandra Millon-Underwood, Malcolm C Pike, Susan D Reed, Audrey F Saftlas, Susan A Scarvalone,[...]. J Natl Cancer Inst 2010
Carmen J Allegra, Denise R Aberle, Pamela Ganschow, Stephen M Hahn, Clara N Lee, Sandra Millon-Underwood, Malcolm C Pike, Susan D Reed, Audrey F Saftlas, Susan A Scarvalone,[...]. J Natl Cancer Inst 2010
7
The natural history of ductal carcinoma in situ of the breast: a review.
Bircan Erbas, Elena Provenzano, Jane Armes, Dorota Gertig. Breast Cancer Res Treat 2006
Bircan Erbas, Elena Provenzano, Jane Armes, Dorota Gertig. Breast Cancer Res Treat 2006
7
Detection of ductal carcinoma in situ in women undergoing screening mammography.
Virginia L Ernster, Rachel Ballard-Barbash, William E Barlow, Yingye Zheng, Donald L Weaver, Gary Cutter, Bonnie C Yankaskas, Robert Rosenberg, Patricia A Carney, Karla Kerlikowske,[...]. J Natl Cancer Inst 2002
Virginia L Ernster, Rachel Ballard-Barbash, William E Barlow, Yingye Zheng, Donald L Weaver, Gary Cutter, Bonnie C Yankaskas, Robert Rosenberg, Patricia A Carney, Karla Kerlikowske,[...]. J Natl Cancer Inst 2002
7
Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Shi-Yi Wang, Tatyana Shamliyan, Beth A Virnig, Robert Kane. Breast Cancer Res Treat 2011
Shi-Yi Wang, Tatyana Shamliyan, Beth A Virnig, Robert Kane. Breast Cancer Res Treat 2011
7
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
7
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
7
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.